Syntara Limited (SWB:UUDA) Financings

Syntara Limited

Financings

RaiseDateIn US dollars
Share purchase plan of new fully paid ordinary shares
Closed: A$840,000 raised · A$0.027 a share
Use of proceeds: Cash runway to Q3 2027: clinical trial readouts and licensing, Phase 2b MF study preparation, patent suite, offer costs
Jun 10, 2026US$589,447
Private placement of new fully paid ordinary shares
Announced: A$8M · A$0.027 a share · Canaccord Genuity (Australia) Limited +1
Dealers: Canaccord Genuity (Australia) Limited (co-lead), Euroz Hartleys Limited (co-lead)
Use of proceeds: Five clinical trial readouts in 2026, licensing discussions, Phase 2b myelofibrosis study preparation, patent suite and offer costs; runway to Q3 2027
Apr 29, 2026US$5.71M

Read by 6ix AI from the company's releases